Delivery Order SPE2DB20D2014-SPE2DB25FB13Z

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,372.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 14, 2023. This award is part of a larger...
This federal contract award is for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, with a ceiling value of $2,608.14. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 16, 2022 with a ceiling value of $1,459.10. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC,...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 29, 2022 with a ceiling value of $1,239.33. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up...
This federal contract award, valued at $1,391.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,120.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order that provides SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,541.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 28, 2022. The contract has an ultimate completion date of September 29, 2022 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award....
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,944.43, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award is for the procurement of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, by the Defense Logistics Agency (DLA). The award, valued at $10,749.02, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 11, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB13Z
    Delivery Order

This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, to the Defense Logistics Agency (DLA). The award, valued at $2,287.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:19 PM